# Cinda Securities

> Cinda Securities is a VC fund in Beijing backing Manufacturing, Military and Logistics. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 11
- Last investment: Aug 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/cinda-securities
- Website: https://www.cindasc.com/

Cinda Securities is a financial service company.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 3 | 27% |
| Military | 2 | 18% |
| Logistics | 2 | 18% |
| News | 1 | 9% |
| Hotel | 1 | 9% |

32 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Post-IPO Equity | 9 | 82% |
| Series B | 1 | 9% |
| Private Equity | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| DFD | DFD is a high-tech enterprise engaged in the research, development, production and sales of high-performance inorganic fluorides. | $37.5M | Post-IPO Equity | Aug 17, 2023 |  |
| Vital Thin Film Materials | Pioneer Thin Film Materials Co., Ltd. is a subsidiary of Pioneer Group, dedicated to R&D, production, sales and recycling of sputtering targets and evaporation materials for vacuum coating. The product series includes targets, ingots, granules and powders made of high-purity metals, alloys, precious metals and ceramic materials, which arewidely used in display, photovoltaic, semiconductor, precision optics, data storage and glass and other fields. | $625M | Series B | Sep 28, 2022 |  |
| Taibang Biological Group | China Biologic Products Holdings, Inc. (NASDAQ: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. Their core capabilities include plasma collection, research and development, manufacturing, and commercialization of human plasma-based biopharmaceutical products. Their company was founded in 2002 and was listed onNASDAQ in 2009.Their products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. Backed by robust research and development capabilities, they aim to capture substantially all of the value along the plasma products value chain, and to develop their technology to enhance life quality and create value for more patients. They have expanded their product portfolio to eight categories of plasma-based products, including human albumin, immunoglobulin for intravenous injection and coagulation factor products, as well as other biopharmaceutical products, and they continue to make progress on new pipeline products. | $300M | Private Equity | Aug 02, 2022 |  |
| SAIBEIGUFEN | SAIBEIGUFEN is a technology company for manufacturing and selling military armored vehicle transmission, steering & motion systems. | $3.8M | Post-IPO Equity | Mar 05, 2018 |  |
| Joint Wisdom | Joint Wisdom provides value-added service for hotel based on big data. | $6.4M | Post-IPO Equity | Dec 08, 2016 |  |
| Ailifang | Ailifang provides childhood education services. They also offer business philosophy, vigorously promote research and development, marketing, training, supply, and management services. | $1.8M | Post-IPO Equity | Apr 27, 2016 |  |
| YUNCHANGGAME.COM | YUNCHANGGAME.COM is a mobile phone game development company. | $14.2M | Post-IPO Equity | Apr 18, 2016 |  |
| Tiexue.net | Tiexue.net is a military news media platform. | $19.6M | Post-IPO Equity | Feb 25, 2016 |  |
| Damon | Damon offers intelligent logistics system solutions. | $2.6M | Post-IPO Equity | Nov 23, 2015 |  |
| Daoyoudao | Daoyoudao is a mobile internet marketing and industrial internet service platform. | $7.1M | Post-IPO Equity | Nov 18, 2015 |  |

10 of 11 investments shown.

## Co-investors
- [CICC](https://shizune.co/investors/profile/cicc) — VC Fund, 5 deals together
- [Changjiang Securities](https://shizune.co/investors/profile/changjiang-securities) — VC Fund, 3 deals together
- [China Merchants Securities](https://shizune.co/investors/profile/china-merchants-securities) — VC Fund, 3 deals together
- Goldstate Securities — VC Fund, 2 deals together
- [Guotai Junan Securities](https://shizune.co/investors/profile/guotai-junan-securities) — VC Fund, 2 deals together
- [Morgan Stanley](https://shizune.co/investors/profile/morgan-stanley) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund
- [KB Securities](https://shizune.co/investors/profile/kb-securities) — VC Fund
- [Frazier Healthcare Partners](https://shizune.co/investors/profile/frazier-healthcare-ventures) — VC Fund

## FAQ

### What does Cinda Securities invest in?

Cinda Securities invests primarily in Manufacturing, Military and Logistics startups, most often at Post-IPO Equity and Series B stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Cinda Securities last invest?

The most recent investment recorded for Cinda Securities closed in Aug 2023. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co